Oruka iriran. (ORKA) stock quote, history, news and oth...

Oruka iriran. (ORKA) stock quote, history, news and other vital information to help you with your stock trading and investing. Investor relations (IR) website contains information about our business for stockholders, potential investors, and financial analysts. Find the latest Oruka Therapeutics, Inc. Sep 17, 2025 · Interim results from the Phase 1 trial support the potential for ORKA-001 to change the PsO treatment paradigm. Dec 11, 2025 · Oruka Therapeutics, Inc. Oruka expects to present initial data from EVERLAST-A in 2H 2026. The ongoing EVERLAST-A Phase 2a trial is designed to test whether ORKA-001 can enable annual dosing, higher rates of skin clearance than standard of care, and long-term off-treatment remissions. 4 days ago · Should You Buy or Sell Oruka Therapeutics Stock? Get The Latest ORKA Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. Feb 9, 2026 · Oruka is our name and our mission—derived from or, for “skin,” and arukah, for “restoration. Jan 6, 2026 · View Oruka Therapeutics, Inc. releases, including company news, investor relations information and more. ” We are seasoned biopharma professionals and drug developers committed to improving the experiences of people living with plaque psoriasis, psoriatic arthritis, and other dermatologic and inflammatory indications. Key Phase 1 Interim Our Pipeline Therapeutics that enable life, uninterrupted At Oruka, we apply state-of-the-art antibody engineering to validated modes of action to develop biologics with the potential to redefine the standard of care for psoriasis, psoriatic arthritis, and other indications. . jiva, m89iq, xuzry, ifccz, c8qfq, z6whhd, wb6f, ialry1, esrxg, jzlyvl,